Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-073065
Filing Date
2011-08-05
Accepted
2011-08-04 18:48:58
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c20581e10vq.htm 10-Q 407261
2 EXHIBIT 31.1 c20581exv31w1.htm EX-31.1 5719
3 EXHIBIT 31.2 c20581exv31w2.htm EX-31.2 5709
4 EXHIBIT 32.1 c20581exv32w1.htm EX-32.1 2495
5 EXHIBIT 32.2 c20581exv32w2.htm EX-32.2 2476
  Complete submission text file 0000950123-11-073065.txt   1556470

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT ogxi-20110630.xml EX-101.INS 170075
7 EX-101 SCHEMA DOCUMENT ogxi-20110630.xsd EX-101.SCH 9243
8 EX-101 CALCULATION LINKBASE DOCUMENT ogxi-20110630_cal.xml EX-101.CAL 26783
9 EX-101 LABELS LINKBASE DOCUMENT ogxi-20110630_lab.xml EX-101.LAB 93231
10 EX-101 PRESENTATION LINKBASE DOCUMENT ogxi-20110630_pre.xml EX-101.PRE 58131
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 111011793
SIC: 2835 In Vitro & In Vivo Diagnostic Substances